by Eric Christianson | May 26, 2021 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I got asked a question the other day about spironolactone. Specifically, how common is gynecomastia with spironolactone? Before I answer that question, let’s take a look at some of the common clinical pearls with spironolactone. Spironolactone classified as a...
by Eric Christianson | May 16, 2021 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
You will see antiarrhythmics used in clinical practice. They are typically prescribed by cardiovascular specialists, but we wanted to provide an antiarrhythmic comparison chart because as a healthcare professional, you still need to monitor for risks and drug...
by Eric Christianson | Mar 28, 2021 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Sacubitril/valsartan (ARNI) is getting more attention in the guidelines with regards to its use in heart failure (specifically HFrEF). Many patients are already on an ACE and making the transition from an ACE inhibitor to an ARNI is likely something you will come...
by Eric Christianson | Nov 18, 2020 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Loop diuretics (podcast episode) are a mainstay of therapy when we need to eliminate fluid from the body. Heart failure and ascites due to cirrhosis are two of the most common fluid overload disease states that these medications will be used for. I wanted to provide...
by Eric Christianson | Nov 4, 2020 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Hydralazine is a medication that causes vasodilation on the arterioles which ultimately leads to a reduction in blood pressure. It isn’t a medication that is used terribly often and I will discuss the reasons for this as well as other hydralazine clinical pearls you...
by Eric Christianson | Aug 12, 2020 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Direct-acting oral anticoagulants (DOACs; also called NOACs – novel oral anticoagulants) are an increasingly popular alternative to warfarin. Meanwhile, the number of obese patients requiring anticoagulation is also increasing. Because the landmark studies that...
